Duloxetine Hydrochloride
Product Images NDC 50436-2995

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Duloxetine Hydrochloride (NDC 50436-2995). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Unit Dose Services, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure1.jpg (Figure1)

This is a graph showing the proportion of patients with relapse over time from randomization to relapse (in days) for a treatment of placebo versus duloxetine. The x-axis represents the time in days, and the y-axis shows the proportion of patients with relapse. However, without more contextual information, it is unclear what this graph pertains to or what the treatment and relapse refer to.*

FDA Label Image

Figure2.jpg (Figure2)

This is a graph showing the proportion of patients with relapse over time after randomization in a clinical trial comparing the treatment groups receiving placebo versus duloxetine. The x-axis represents the time from randomization to relapse in days, and the y-axis shows the proportion of patients with relapse, ranging from 0.06 to 0.1. There are no other details or information available in the given text.*

FDA Label Image

Figure3.jpg (Figure3)

FDA Label Image

Figure4.jpg (Figure4)

FDA Label Image

Figure5.jpg (Figure5)

This is a chart or graph showing the percent improvement in pain from the baseline for a treatment that includes placebo and duloxetine doses of 60mg/120mg taken once daily. There are no additional details available.*

FDA Label Image

Figure6.jpg (Figure6)

FDA Label Image

Figure7.jpg (Figure7)

The text describes the percentage of improvement in patients treated with a placebo and Duloxetine 60/120 mg once daily. The percentage of patients improved is 100. There is also a graph that shows the percent improvement in pain from baseline (BOCF).*

FDA Label Image

Dulostructure (Dulostructure)

FDA Label Image

Label Image (Lbl504362995)

This is a medication called Duloxetine Hydrochloride, with a strength of 20mg and a package size of 60 capsules. The manufacturer is Apotex located in Toronto. The NDC number is 5043629952. It appears to be a delayed-release medication. No further information is available such as usage, indications, or warnings.*

FDA Label Image

Label Image (Lbl504362996)

This is a medication for oral use with NDC number 50436-2996-1 containing DULOXETINE HYDROCHLORIDE in delayed-release form. Each capsule has a strength of 30 mg and contains 337 mg of Dioketne Hycrochiorde equal to 30 mg of Duloxtie. It is manufactured by Apotex Inc. in Canada and the lot number is X000 with an expiration date of 30000. The medication is only available through a prescription.*

FDA Label Image

Label Image (Lbl504362997)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.